🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Chatbot Implementation In The Clinical Informed Consent Process

RecruitingNAAges 18 Years - anyAllM.D. Anderson Cancer Center
NCT07756515 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to determine the feasibility of implementing the chatbot "CoCo" in the IC process for research studies. We hypothesize that implementing a chatbot into the IC process will facilitate accurate information delivery and enhance participant comprehension and process satisfaction compared to traditional remote consent methods.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Ability to understand and willingness to provide informed consent. * Age ≥18 years. * Patients whose preferred language is English. * Patients who are being considered for enrollment in selected clinical research studies. Phase I will be initiated using the Clearinghouse protocol PA11-0852, a non-interventional biomarker study. Exclusion Criteria: N/A
💊

What it tests

  • CoCo Chatbot
📍

Where

1 site
UT MD Anderson
Houston, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy